Statizoid

Cyprus vs Norway: Statin use vs. average non-HDL cholesterol levels

Cyprus
3.5
in 2018
Norway
3.5
in 2018
Cyprus rank
52nd
Norway rank
52nd

Statin use vs. average non-HDL cholesterol levels over time

  • Cyprus
  • Norway
012345198019992018

How they compare

Cyprus currently reports 3.5 against 3.5 in Norway, a difference of 0.

The two have swapped places 2 times across 39 shared years of data; in 1980 it was Norway ahead.

Cyprus ranks 52nd and Norway ranks 52nd of 191 countries.

Individual pages

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.